证券代码：603168 证券简称：莎普爱思 公告编号：临 2025-067 浙江莎普爱思药业股份有限公司 关于召开 2025 年第二次临时股东会的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 浙江莎普爱思药业股份有限公司（以下简称"公司"）于2025年10月30日召 开的第六届董事会第十一次会议审议通过了《关于豁免第六届董事会第十一次会 议通知期限的议案》、《关于2025年第三季度报告的议案》等议案，其中《关于 修订<公司章程>的议案》需提交公司2025年第二次临时股东会审议，详细内容请 见公司于2025年10月31日在《中国证券报》、《上海证券报》、《证券时报》、 《证券日报》和上海证券交易所网站（www.sse.com.cn）上披露的公告。 为确保公司股东充分了解本次股东会的相关信息，现将相关事项提示公告如 下： 一、 召开会议的基本情况 (一)股东会类型和届次：2025 年第二次临时股东会 (二)股东 ...

浙江莎普爱思药业股份有限公司 2025 年第二次临时股东会会议资料 浙江莎普爱思药业股份有限公司 2025 年第二次临时股东会 会 议 资 料 二〇二五年十一月十九日 1 浙江莎普爱思药业股份有限公司 2025 年第二次临时股东会会议资料 目 录 | 2025 年第二次临时股东会会议须知 | 3 | | --- | --- | | 2025 年第二次临时股东会会议议程 | 5 | | 2025 年第二次临时股东会会议议案 | 6 | | 议案一：关于修订《公司章程》的议案 | 6 | 2 浙江莎普爱思药业股份有限公司 2025 年第二次临时股东会会议资料 浙江莎普爱思药业股份有限公司 2025 年第二次临时股东会会议须知 为了维护全体股东的合法权益，确保股东会的正常秩序和议事效率，保证大会 的顺利进行，根据《公司章程》、公司《股东会议事规则》等相关法律法规的要求， 特制定 2025 年第二次临时股东会会议须知。 浙江莎普爱思药业股份有限公司 2025 年第二次临时股东会会议资料 七、本次股东会由公司聘请的北京市金杜律师事务所律师现场见证并出具法律 意见书。 八、股东出席本次股东会所产生的费用由股东自行承担。公 ...

Core Viewpoint - Zhejiang Shapuaisi Pharmaceutical Co., Ltd. is set to hold a Q3 2025 performance briefing on November 18, 2025, to enhance investor understanding of its operational performance and development strategy [3][4]. Group 1: Meeting Details - The performance briefing will take place on November 18, 2025, from 15:30 to 16:30 [4]. - The meeting will be conducted online via the "Value Online" platform [4]. - Key personnel attending the meeting include Chairman Lin Hongli, Independent Director Chen Shengqun, CFO Lin Xiusong, and Board Secretary Huang Mingxiong [4]. Group 2: Investor Participation - Investors can submit questions before the meeting until November 18, 2025, through a designated website or by scanning a QR code [2][5]. - During the briefing, the company will address common investor concerns within the scope of information disclosure [2][5]. Group 3: Contact Information - For inquiries, investors can contact Huang Mingxiong or Wang Yu via phone, fax, or email [6].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、说明会类型 证券代码：603168 证券简称：莎普爱思 公告编号：临2025-066 浙江莎普爱思药业股份有限公司 关于召开2025年三季度业绩说明会的公告 公司已于 2025 年 10 月 31 日在上海证券交易所网站（www.sse.com.cn）披 露了《浙江莎普爱思药业股份有限公司 2025 年三季度报告》。为便于广大投资 者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2025 年 11 月 18 日（星期二）15:30-16:30 在"价值在线"（www.ir-online.cn）举办浙江莎普 会议召开时间：2025 年 11 月 18 日（星期二）15:30-16:30 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 会 议 问 题 征 集 ： 投 资 者 可 于 2025 年 11 月 18 日 前 访 问 网 址 https://eseb.cn/1sTxE55zVx6 或使用微信扫描下方小程 ...

Core Viewpoint - On November 10, a total of 10 listed companies will have their restricted shares unlocked, with a total market value of approximately 9.248 billion yuan [1] Summary by Category Restricted Share Unlocking - The companies involved in the unlocking of restricted shares include: - Antai Technology (Stock Code: 000969) with 488,400 shares from equity incentive restrictions - Fenghuo Communication (Stock Code: 600498) with 18.4 million shares from equity incentive restrictions - Supor (Stock Code: 002032) with 604,000 shares from equity incentive restrictions - Shapuaisi (Stock Code: 603168) with 49.9215 million shares from A-share issuance to legal person placement - Zhujiang Piano (Stock Code: 002678) with 152,700 shares from equity incentive restrictions - Chuangli Group (Stock Code: 603012) with 32,400 shares from equity incentive restrictions - Xianle Health (Stock Code: 300791) with 31,950 shares from equity incentive restrictions - Southeast Electronics (Stock Code: 301359) with 57.9959 million shares from pre-issue share restrictions - Lihang Technology (Stock Code: 603261) with 40,740 shares from equity incentive restrictions - Youyan Silicon (Stock Code: 688432) with 740 million shares [1]

Group 1 - The State Council will hold a press conference to discuss the acceleration of scenario cultivation and the large-scale application of new scenarios [2] - Domestic oil prices are expected to rise for the seventh time this year, with the new pricing window opening on November 10 [3] - The HPV vaccine will be included in the national immunization program starting November 10, 2025, for girls born after November 10, 2011 [4] Group 2 - A total of 13 companies will have their restricted shares unlocked today, with a combined market value of 12.143 billion yuan [5] - The companies with the largest number of unlocked shares include Youyan Silicon, Shapuaisi, and Southeast Electronics, with respective unlock volumes of 74 million shares, 4.99215 million shares, and 3.25328 million shares [5] - The companies with the highest market value of unlocked shares are Youyan Silicon, Southeast Electronics, and Shapuaisi, with respective values of 9.991 billion yuan, 677 million yuan, and 403 million yuan [5]

Core Viewpoint - On November 10, a total of 13 companies had their restricted shares unlocked, with a total unlock volume of 846 million shares, amounting to a market value of 12.143 billion yuan based on the latest closing prices [1] Summary by Category Unlock Volume - Three companies had unlock volumes exceeding 10 million shares: Youyan Silicon (74 million shares), Shapuaisi (4.99215 million shares), and Southeast Electronics (3.25328 million shares) [1] Unlock Market Value - The three companies with the highest unlock market values were Youyan Silicon (9.991 billion yuan), Southeast Electronics (677 million yuan), and Shapuaisi (403 million yuan) [1]

Core Viewpoint - On November 10, a total of 13 companies had their restricted shares unlocked, with a total unlock volume of 846 million shares, amounting to a market value of 12.143 billion yuan based on the latest closing price [1] Summary by Category Unlock Volume - Three companies had unlock volumes exceeding 10 million shares: Aoyang Silicon, Shapuaisi, and Southeast Electronics, with unlock volumes of 740 million shares, 49.9215 million shares, and 32.5328 million shares respectively [1] Unlock Market Value - The three companies with the highest unlock market value were Aoyang Silicon, Southeast Electronics, and Shapuaisi, with unlock market values of 9.991 billion yuan, 677 million yuan, and 403 million yuan respectively [1] Unlock Ratio - The three companies with the highest unlock ratio relative to total share capital were Aoyang Silicon, Southeast Electronics, and Shapuaisi, with unlock ratios of 59.32%, 27.07%, and 13.34% respectively [1]

Core Points - The company announced that the restricted shares to be listed for circulation are from a non-public offering, totaling 49.9215 million shares, which accounts for 13.34% of the company's total share capital [1] - The listing date for these shares is set for November 10, 2025, with the issuance targets being Shanghai Yanghe Industrial Co., Ltd. and Lin Hongyuan [1] - The company received approval for the non-public offering in November 2021, and the new shares were registered in November 2022, with a lock-up period of 36 months [1] - Due to changes from incentive plan share grants and repurchases, the current total share capital stands at 374,126,505 shares [1] - The sponsor institution has no objections to the listing of these restricted shares [1]

证券代码：603168 证券简称：莎普爱思 公告编号：2025-065 浙江莎普爱思药业股份有限公司 非公开发行股票限售股上市流通的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 责任公司上海分公司办理完毕登记托管相关事宜，中国证券登记结算有限责任公 司上海分公司出具了《证券变更登记证明》。 本次股票上市类型为非公开发行股份；股票认购方式为网下，上市股数为 49,921,506股。 本次股票上市流通总数为49,921,506股。 本次股票上市流通日期为2025 年 11 月 10 日。 一、本次限售股上市类型 浙江莎普爱思药业股份有限公司（以下简称"公司"）本次上市流通的限售股 类型为非公开发行股票限售股。 （一）非公开发行股票核准情况 2021年11月15日，中国证券监督管理委员会出具的《关于核准浙江莎普爱思 药业股份有限公司非公开发行股票的批复》（证监许可[2021]3633号），核准公司非 公开发行股票。 （二）发行股票登记情况 本次发行新增49,921,506股股份已于2022年11月8日在中 ...